Amplify Treatments, Testing And Advancements ETF PCVX Holdings History
Amplify Treatments, Testing and Advancements ETF's Vaxcyte Inc Holding Summary
As of 2024-06-30, Amplify Treatments, Testing and Advancements ETF held 5,397.00 shares of Vaxcyte Inc(PCVX), totaling $407,530.00. This investment constitutes 4.46% of their stock portfolio, and Amplify Treatments, Testing and Advancements ETF now holds 0% of the outstanding Vaxcyte Inc(PCVX) stock.
The initial trade took place in 2024Q1. In addition, there have been 1 sales at an average price of $68.07 for 531.00 shares. Based on historical transaction data and PCVX's current price of $36.95, Amplify Treatments, Testing and Advancements ETF's estimated gain on his PCVX holdings is $-174,976.67, reflecting a -42.62% gain to date.
Amplify Treatments, Testing and Advancements ETF PCVX ($36.95) Holding Chart
Amplify Treatments, Testing and Advancements ETF PCVX ($36.95) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
